Sevacizumab
Sponsors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Conditions
Advanced Solid TumorsMetastatic Colorectal CancerMetastatic Solid TumorsOvarian Cancer
Phase 1
A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors
NCT01847118
Start: 2013-04-30End: 2015-11-30Target: 31Updated: 2015-03-24
A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer
NCT02453464
Start: 2015-08-31Target: 36Updated: 2016-04-20
A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
NCT03763123
Start: 2018-04-24End: 2020-12-31Target: 48Updated: 2018-12-04